PEHSU Annual Meeting: Reproductive Environmental Health: Marijuana Use in Pregnancy and While Breastfeeding

The following presentations were given at the 2019 PEHSU Annual Meeting.

The presentations focus on the impact of environmental exposures to chemicals on human health at the vulnerable stages of in utero and pediatric development. A number of topics will be included – all of them relevant to questions of exposure and health effects, with consideration of risk reduction. Speakers will include physicians and PhD subject matter experts, as well as individuals with expertise in areas such as home assessment, laboratory analysis, and risk communication.

Learning Objectives By the end of this module, participants should be able to:

• Define prevalence of marijuana use in pregnancy and reported reasons for use.
• Counsel women regarding the risks of marijuana use during pregnancy and lactation based on the current evidence.
• Create health messaging for patients around marijuana use in pregnancy

Moderator

     Blair Wylie, MD, MPH, FACOG, Region 1 PEHSU Marijuana and Pregnancy

Presenter 

Marijuana and Pregnancy 

Torri Metz, MD, MS, FACOG, Associate Professor, Obstetrics and           
Gynecology, Director of Perinatal Research, University of Utah Health

Dr. Metz is an Associate Professor of Obstetrics and Gynecology and a maternal-fetal medicine specialist at University of Utah Health, where she is also the Director of Perinatal Research. Dr. Metz completed both her medical school and residency training at the University of Colorado. She then went on to complete her Maternal-Fetal Medicine fellowship and Masters of Science in Clinical Investigation at the University of Utah in 2012. Dr. Metz currently chairs the Society for Maternal-Fetal Medicine Fellowship Affairs Committee and is a member of the ACOG Committee on Practice Bulletins-Obstetrics as well as the SMFM Publications Committee. She has received numerous teaching awards including the ACOG District VIII Mentor of the Year Award, and the National CREOG Award for Excellence in Resident Education. Her research interests include marijuana use in pregnancy, maternal congenital heart disease, and factors influencing maternal mortality. She is a recognized national expert in marijuana use in pregnancy and is currently a member of the editorial board for Obstetrics and Gynecology.

Message Mapping Activity

Susan Buchanan, MD, MPH, FAAFP, Region 5 PEHSU

Dr. Buchanan is Director of the Great Lakes Center for Children’s Environmental Health at the University of Illinois at Chicago (UIC) which is the Pediatric Environmental Health Specialty Unit (PEHSU) for federal Region 5. Dr. Buchanan is board certified in Family Medicine and Occupational and Environmental Medicine. She teaches occupational and environmental health topics in UIC’s Occupational Medicine Residency Program, Family Medicine Department, and School of Public Health Her research interest include the safety and occupational health of low income and immigrant workers as well as environmental exposures to children and women of childbearing age.

CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Charles A. McKay and he wishes to disclose that he is a member of the Scientific Advisory Council, Environmental Health Research Foundation (EHRF). EHRF addresses issues related to biomonitoring, a topic that is also relevant to some of the activities in the Grand Round Series that might be discussed in future sessions. EHRF receives funding from sources that includes industry. Dr. McKay has reviewed and written material for EHRF, that could create a perceived conflict of interest regarding environmental chemical exposure assessment/measurement.

Planning committee discussed conflict of interest with Dr. Charles A. McKay to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC does not accept commercial support.

Disclaimer: This material was supported by the American Academy of Pediatrics (AAP) and funded (in part) by the cooperative agreement FAIN: 5 NU61TS000237-05 along with the American College of Medical Toxicology and funded (in part) by the cooperative agreement FAIN: 5U61TS000238-05 from the Agency for Toxic Substances and Disease Registry (ATSDR). Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications. Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications.

WD2588-060319B